SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057050
Filing Date
2024-05-09
Accepted
2024-05-09 16:25:41
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20240331.htm   iXBRL 10-Q 1427941
2 EX-31.1 orgo-ex31_1.htm EX-31.1 14442
3 EX-31.2 orgo-ex31_2.htm EX-31.2 14958
4 EX-32.1 orgo-ex32_1.htm EX-32.1 14185
  Complete submission text file 0000950170-24-057050.txt   7561939

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20240331.xsd EX-101.SCH 1379045
84 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20240331_htm.xml XML 1253695
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 24931140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)